Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
ACTM-838
i
Other names:
ACTM-838
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Actym Therap
Drug class:
STING agonist, IL-15R stimulant
Related drugs:
‹
CS-1018 (2)
XMT-2056 (2)
CS-1010 (1)
CS-1020 (1)
TAK-500 (1)
ADU-S100 (0)
BI 1387446 (0)
E7766 (0)
GSK3745417 (0)
IMSA101 (0)
MK-2118 (0)
ONM-501 (0)
SB 11285 (0)
SYNB1891 (0)
TSN222 (0)
TAK-676 (0)
exoSTING (0)
MK-1454 (0)
FT596 (2)
SAR445710 (2)
AGAR T cells (0)
FT538 (0)
GT-00A x IL15 (0)
GTB-3550 TRIKE (0)
GTB-3650 (0)
HCW9218 (0)
NIZ985 (0)
PF-07209960 (0)
RPTR-147:1 (0)
RTX-240 (0)
SAR445877 (0)
VG161 (0)
VG201 (0)
iC9.GD2.CAR.IL-15 T-cells (0)
CS-1018 (2)
XMT-2056 (2)
CS-1010 (1)
CS-1020 (1)
TAK-500 (1)
ADU-S100 (0)
BI 1387446 (0)
E7766 (0)
GSK3745417 (0)
IMSA101 (0)
MK-2118 (0)
ONM-501 (0)
SB 11285 (0)
SYNB1891 (0)
TSN222 (0)
TAK-676 (0)
exoSTING (0)
MK-1454 (0)
FT596 (2)
SAR445710 (2)
AGAR T cells (0)
FT538 (0)
GT-00A x IL15 (0)
GTB-3550 TRIKE (0)
GTB-3650 (0)
HCW9218 (0)
NIZ985 (0)
PF-07209960 (0)
RPTR-147:1 (0)
RTX-240 (0)
SAR445877 (0)
VG161 (0)
VG201 (0)
iC9.GD2.CAR.IL-15 T-cells (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login